Wells Fargo
NPCE icon

Wells Fargo’s Neuropace NPCE Stock Holding History

Wells Fargo’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$436K Buy
27,417
+12,934
+89% +$208K ﹤0.01% 4722
2026
Q1 		$190K Sell
14,483
-18,605
-56% -$279K ﹤0.01% 4726
2025
Q4 		$511K Buy
33,088
+13,078
+65% +$175K ﹤0.01% 4481
2025
Q3 		$206K Buy
20,010
+4,145
+26% +$39.1K ﹤0.01% 4916
2025
Q2 		$177K Sell
15,865
-9,485
-37% -$119K ﹤0.01% 4840
2025
Q1 		$312K Buy
25,350
+18,867
+291% +$236K ﹤0.01% 4402
2024
Q4 		$72.5K Buy
6,483
+2,279
+54% +$19.8K ﹤0.01% 5356
2024
Q3 		$29.3K Sell
4,204
-2,166
-34% -$15.8K ﹤0.01% 5532
2024
Q2 		$48.2K Buy
6,370
+4,288
+206% +$43.3K ﹤0.01% 5309
2024
Q1 		$27.5K Buy
2,082
+2,001
+2,470% +$28.5K ﹤0.01% 5475
2023
Q4 		$835 Buy
81
+7
+9% +$56 ﹤0.01% 6269
2023
Q3 		$720 Sell
74
-149
-67% -$872 ﹤0.01% 6277
2023
Q2 		$1K Buy
223
+4
+2% +$18 ﹤0.01% 6321
2023
Q1 		$1.02K Buy
219
+151
+222% +$578 ﹤0.01% 6371
2022
Q4 		$101 Sell
68
-18
-21% -$40 ﹤0.01% 6791
2022
Q3 		$0 Buy
86
+43
+100% +$207 ﹤0.01% 7135
2022
Q2 		$0 Sell
43
-1,553
-97% -$10.3K ﹤0.01% 7263
2022
Q1 		$13K Sell
1,596
-2,475
-61% -$21.4K ﹤0.01% 6176
2021
Q4 		$41K Sell
4,071
-6,108
-60% -$79.3K ﹤0.01% 6063
2021
Q3 		$161K Sell
10,179
-42
-0.4% -$882 ﹤0.01% 5196
2021
Q2 		$243K Buy
+10,221
New +$237K ﹤0.01% 4947

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Wells Fargo's NPCE Position: Q2 2026 in Review

Wells Fargo increased its Neuropace (NPCE) stake by 89% in Q2 2026, buying an estimated $208K and bringing the position to 27,417 shares worth $436K. The position accounts for ﹤0.01% of the portfolio, ranked #4722.

Wells Fargo first reported a position in NPCE in Q2 2021 and has held it in 21 quarters since. The position peaked at $511K in Q4 2025. 113 funds tracked by Wall St. Rank hold NPCE as of Q2 2026.

  • Wells Fargo held 27,417 shares of Neuropace worth $436K as of Q2 2026.
  • Wells Fargo bought 12,934 Neuropace shares in Q2 2026, an estimated $208K.
  • Neuropace made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #4722 holding.
  • Wells Fargo first reported a position in Neuropace in Q2 2021 and has held it in 21 quarters since.
  • Wells Fargo's Neuropace position peaked at $511K in Q4 2025.
  • 113 funds tracked by Wall St. Rank held Neuropace as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.